Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zhenmei Gao"'
Autor:
Xianli Hu, Bo Hou, Zhiai Xu, Madiha Saeed, Fang Sun, Zhenmei Gao, Yi Lai, Tong Zhu, Fan Zhang, Wen Zhang, Haijun Yu
Publikováno v:
Advanced Science, Vol 7, Iss 8, Pp n/a-n/a (2020)
Abstract Immunotherapy aiming to harness the exquisite power of the immune system has emerged as a crucial part of clinical cancer management. However, only a subset of cancer patients responds to current immunotherapy because of low immunogenicity o
Externí odkaz:
https://doaj.org/article/566cd7e6db0d410384ef91d066ce9453
Publikováno v:
Journal of Medicinal Chemistry. 63:3028-3046
PI3K-Akt-mTOR signaling pathway has been validated as an effective targeting pathway for cancer therapy. However, no PI3K/mTOR dual inhibitor has been approved by the FDA yet. Therefore, it is still essential to discover a candidate with good efficac
Publikováno v:
Journal of medicinal chemistry. 63(6)
PI3K-Akt-mTOR signaling pathway has been validated as an effective targeting pathway for cancer therapy. However, no PI3K/mTOR dual inhibitor has been approved by the FDA yet. Therefore, it is still essential to discover a candidate with good efficac
Publikováno v:
Chemical Physics Letters. 741:137126
The smoothened receptor (SMO) plays a critical role in embryonic development. Vismodegib was approved by the FDA to treat metastatic basal-cell carcinoma. However, The D473H mutation can cause obvious drug resistance toward Vismodegib. In this work,
Publikováno v:
Rehabilitation Medicine. 27:10
Publikováno v:
Acta Microscopica. 2020, Vol. 29 Issue 6, p3266-3274. 9p.